Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-12

Clinical Trial Update: A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 drug-drug interaction study evaluating abiraterone acetate plus prednisone with dextromethorphan and theophylline in metastatic castration-resistant p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Zytiga) (abiraterone acetate)
  • Dextromethorphan (dextromethorphan)
  • PREDNISONE (Prednisone)
  • Theophylline (Theophylline)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostate Neoplasms | Phase 1 | Status: COMPLETED